Atopic dermatitis (eczema) trials in China
5 of 57 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleThis Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Where
- Beijing, Changsha, Chengdu, Chongqing, Hangzhou, Ningbo, Shanghai, Shenzhen, Xi’an
- Age
- 12 years and over
- People
- 1,000 worldwide
- Run by
- Sanofi
See details and how to joinNCT07290803 - No phaseTaking peopleAssessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
- Where
- Nanjing
- Age
- 18 years and over
- People
- 80
- Run by
- Zhongda Hospital
See details and how to joinNCT07573735 - No phaseEnrolling by invitationA Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
- Where
- Shanghai
- Age
- 18 years to 65 years
- People
- 50
- Run by
- Xi Tan
See details and how to joinNCT06999941 - No phaseTaking peopleA Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
- Where
- Beijing
- Age
- 18 years and over
- People
- 1,000
- Run by
- Chengdu Kangnuoxing Biopharma,Inc.
See details and how to joinNCT07544862 - No phaseTaking peopleChina Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
- Where
- Beijing
- People
- 100,000
- Run by
- Peking University First Hospital
See details and how to joinNCT05316805